Category: Partners

  • Epique Realty CFO and Co-Founder, Janice Delcid Honored as a 2025 Global Woman of Influence

    Epique Realty CFO and Co-Founder, Janice Delcid Honored as a 2025 Global Woman of Influence

    CFO and Mother of Seven Recognized for Driving Transformative Impact and Change in Real Estate

    HOUSTON, TX / ACCESS Newswire / September 2, 2025 / Epique Realty is beyond proud to announce that its very own Chief Financial Officer and Co-Founder, Janice Delcid, has been named a winner of the prestigious 2025 Global Women of Influence Award. Selected from a competitive and multidisciplinary field of applicants worldwide, this award celebrates extraordinary women who have demonstrated exceptional leadership and made a transformative impact on society.

    Janice Delcid was recognized for shattering industry barriers by co-founding one of the first national woman-owned brokerages in history and for architecting the company’s revolutionary “radical generosity” financial model. Her fellow co-founders celebrated her as the heart and soul of Epique’s success.

    “I could not ask for a better partner in this journey,” said Joshua Miller, CEO and Co-Founder. “Janice is an excellent financial architect who has proven that a business model rooted in generosity can be wildly successful. She is a force for good, and this award honors the profound impact she has on our company and on every person and community she touches.”

    “Janice is the cultural cornerstone of Epique,” said Christopher Miller, COO and Co-Founder. “She ensures that every decision we make is guided by compassion, integrity, and a genuine desire to uplift others. She is more than a CFO. She is a visionary, a mentor, and a humanitarian who has proven that a woman of influence doesn’t just build a successful company, she builds a better, more compassionate world along with it. This global recognition is a perfect tribute to the incredible family she has built within our company.”

    As CFO, Janice has helped steer Epique’s growth from a regional startup to a 50-state powerhouse with over 4,000 agents. Beyond her financial acumen, she has spearheaded the company’s philanthropic initiatives, including a drive to deliver 10,000 backpacks to children in need and the creation of NEMO, an agent-led disaster relief organization. She also championed another new program, Epique Cares, a non-profit initiative where contributions are made from the heart, without tax incentives, purely to support those in need.

    “I am deeply humbled and grateful to receive this incredible honor alongside so many inspiring women,” said Janice Delcid. “To me, this award is a celebration of what’s possible when you lead with both your head and your heart. I share this recognition with my entire Epique family and hope that it inspires other women to build their own tables and lead with purpose.”

    About Epique Realty
    Shaping the future of housing, Epique Realty is one of the fastest-growing real estate brokers. Epique now operates in all fifty states with over 4,000 agents and global expansion underway. Its revolutionary agent-first model provides unheard of free extensive benefits with award-winning AI and a culture of radical generosity. By questioning industry norms and putting agents at the center of its universe, Epique is transforming and defining the future of real estate.#BeEpique

    Barbara Simpson | PR and Communications
    281-773-7842 | Barbara@EpiqueRealty.com

    https://www.instagram.com/epiquerealty/
    https://www.facebook.com/epiquerealty
    https://www.linkedin.com/company/epique-realty/mycompany/
    https://www.youtube.com/@epiquerealty

    SOURCE: Epique Realty

    View the original press release on ACCESS Newswire

    The post Epique Realty CFO and Co-Founder, Janice Delcid Honored as a 2025 Global Woman of Influence appeared first on DA80 Hub.

  • Arrowhead Clinic in Duluth Unveils 24-Hour Post-Accident Recovery Program

    Arrowhead Clinic in Duluth Unveils 24-Hour Post-Accident Recovery Program

    Duluth, Georgia – September 02, 2025 – (PRESS ADVANTAGE) –

    Arrowhead Clinic in Duluth, Georgia, has launched a new healthcare program aimed at helping car accident victims right after they get hurt. The focus is on giving them the care they need within the first 24 hours after an accident. This time frame is important because it can prevent injuries from getting worse. The updated services are now designed to make post-accident care faster and easier, and the clinic is ready to welcome walk-in patients who need urgent help.

    The clinic offers quick medical check-ups, detailed injury reports, diagnostics using advanced testing methods, and same-day chiropractic appointments for those feeling pain after an accident. They have also prepared a guide to help accident victims through what needs to be done in those first 24 hours. The guide covers keeping safe, contacting emergency services, and setting up needed same day evaluations.

    Dr. Darris Gentry, DC, from Arrowhead Clinic shared why this is so important. “Our goal is to give quick and effective care to our patients who have been in an auto accident,” he said. “It’s not just about treatment; it’s also about education and support during those important first 24 hours.” Through this effort, Arrowhead Clinic aims to help patients manage their health needs and navigate any legal issues following an accident.

    Not only do they provide urgent medical assessments, but they also offer a complete recovery plan. This includes careful tracking of symptoms, coordination with other healthcare providers and legal consultants, and the use of advanced tools to find the exact cause of pain or injury. Their all-around approach makes sure that patients receive comprehensive care.

    An Arrowhead Clinic in Duluth review praised the clinic for its commitment. The reviewer appreciated the attentive and well-organized staff. They noted that the clinic handled her case efficiently, offering valuable support and information which helped her manage her first accident experience better. Such positive feedback shows the clinic’s dedication to delivering high-quality care and ensuring a good experience for patients.

    Arrowhead Clinic also supports patients beyond just health services. They offer referrals to personal injury attorneys to help patients deal with legal matters and reduce the financial stress that accidents often bring. The clinic provides specialized treatments, including for whiplash and other musculoskeletal issues resulting from truck, car, and motorcycle accidents, along with a range of other injuries from sports, work, and slip and fall incidents. Arrowhead Clinic has been offering chiropractic care for injury victims for over 48 years and continuously updates its methods to keep up with modern practices. This ensures that patients get access to the newest and most efficient treatments.

    Dr. Gentry emphasized the clinic’s broad services for car accident victims. “Our clinic is dedicated to combining expert chiropractic treatment with a caring approach,” he noted. He pointed out that their consistent effort to assist first-time patients and guide them through every recovery stage is what makes the clinic unique.

    For those looking for auto accident treatment from Arrowhead Clinic in Duluth, the clinic’s new initiative focuses on quick responses and personalized care for each case. This aims to support patients during difficult times, helping with physical recovery and giving peace of mind.

    Arrowhead Clinic in Duluth is open every week and provides same-day appointments and walk-in services. This highlights their commitment to being easily accessible for everyone needing immediate care. With a focus on patient comfort and understanding, Arrowhead Clinic ensures that people involved in auto accidents receive comprehensive care that promotes healing and recovery As a recognized Arrowhead Clinic Chiropractor in Duluth GA, the clinic is committed to maintaining its reputation by constantly enhancing treatment services and patient care..

    Patients can also benefit from various resources available through Arrowhead Clinic, including a chiropractic blog, a car accident guide, a chiropractic care guide, and wellness options. Arrowhead Clinic invites those who need care to visit their website or visit them directly.

    ###

    For more information about Arrowhead Clinic – Duluth, contact the company here:

    Arrowhead Clinic – Duluth
    Dr. Darris Gentry, DC
    (770) 525-1431
    info@arrowheadclinics.com
    2131 Pleasant Hill Rd #122, Duluth, GA 30096

    The post Arrowhead Clinic in Duluth Unveils 24-Hour Post-Accident Recovery Program appeared first on DA80 Hub.

  • Florence Announces AI-Assisted Workflows to Transform Clinical Trials

    Florence Announces AI-Assisted Workflows to Transform Clinical Trials

    ATLANTA, GA / ACCESS Newswire / September 2, 2025 / Ahead of its premier life science event advancing Clinical Trial technology and innovation, Research Revolution, Florence Healthcare today announced its upcoming AI-centric workflows aimed at transforming clinical trials conducted across the study life-cycle. These solutions will significantly accelerate and enhance site identification, feasibility, start up, study conduct and remote monitoring for both sites and sponsors.

    Built in collaboration with top sponsors, CRO partners, and hundreds of research sites; these new Human-in-loop (HITL) AI capabilities are built to supercharge clinical trial professionals as they tackle some of the most persistent challenges in the industry:

    • Limited Visibility Into Site Performance: Sponsors struggle to identify the right research sites, relying on disparate and stagnant data sources that provide limited visibility into true site capacity and performance.

    • Inefficient Study Start-Up Processes: Timelines are bogged down by manual and fragmented workflows and communication across stakeholders. Meaning critical data and documents are trapped in email chains, portals, and spreadsheets- causing version control issues, compliance risks, and inefficiencies.

    • Fragmented Oversight & Monitoring: Fragmented data and documents means that sponsor oversight is limited. Disparate systems prevent monitors from having real-time visibility into trial progress. As a consequence, costly physical site visits are still needed.

    AI Assisted workflows will be available to Sponsors, CROs and Research Sites in October 2025

    Florence Healthcare will introduce modules to directly address the challenges listed above. These will include:

    • Site Identification & Feasibility: Utilizing these new workflows, Sponsors will be able to quickly search across site profiles according to therapeutic area, geography, and real-time performance criteria to pick the right sites for study startup. From there they can deliver protocol-specific feasibility surveys, focusing on questions that are informative rather than repetitive. Sites will then be able to leverage an AI-driven workflow to accelerate survey completion with context-specific responses highlighting Site qualifications for the specific study.

    • Study Start-Up: New AI-driven contract negotiations will accelerate time to startup, in compliance with Site and Sponsor guidelines for contracts. In addition, a fully automated document exchange with Site eISF will provide the flexibility to tailor documents to specific Site networks or regions. The enhanced AI workflows will also simplify document management across startup and trial conduct, reducing administrative work for sites and sponsors.

    • Remote Monitoring: Remote Monitoring will also receive an AI upgrade. New reports providing deeper insights into Study progress across Sites or at specific sites will be available, allowing for quick intervention and remediation to keep trials on track, and obviating the need for physical site visits.

    These AI-centric product workflows will enter limited availability in October 2025 for early adopters. These workflows are built on Florence’s validated and GxP-compliant infrastructure-trusted by over 37,000 research sites globally. They include full audit traceability, 21 CFR Part 11 support, and interoperability APIs for CTMS, eTMF, and identity systems.

    “We’re not just automating the trial conduct for speed,” said Shankar Jagannathan, COO at Florence. “We’re creating a shared, AI-augmented experience between sponsors and sites to reduce manual work and increasing capacity, while minimizing risk -one that’s more intelligent, scalable, and efficient.”

    About Florence Healthcare

    Florence is a purpose-built platform that connects sponsors and sites to accelerate clinical trials, improve operational capacity, and reduce risk. Designed for scale, Florence streamlines workflows, enhances collaboration, and delivers real-time visibility across studies-empowering research teams to move faster, stay inspection-ready, and increase trial throughput with fewer resources.

    For more information, visit www.florencehc.com

    Press Contact:

    Lautel Okhio
    Communications, Florence
    press@florencehc.com

    SOURCE: Florence Healthcare

    View the original press release on ACCESS Newswire

    The post Florence Announces AI-Assisted Workflows to Transform Clinical Trials appeared first on DA80 Hub.

  • Dateline Resources Completes $25M Institutional Placement Priced at $0.215 to Accelerate Development at Colosseum Gold and Rare Earth Project

    Dateline Resources Completes $25M Institutional Placement Priced at $0.215 to Accelerate Development at Colosseum Gold and Rare Earth Project

    Dateline to Engage US Securities Counsel and Auditing Firm to Initiate SEC Registration and Reporting Compliance

    SYDNEY, AU / ACCESS Newswire / September 2, 2025 / Dateline Resources Limited (OTCQB:DTREF)(ASX:DTR) (“Dateline” or the “Company”), a leading explorer and developer of high-value mineral assets, announces the completion of a $25 million institutional placement, reflecting strong investor confidence in the Company’s strategic direction and the potential of its flagship Colosseum Gold and Rare Earth Elements (REE) Project in San Bernardino County, California. The issue was heavily oversubscribed and was conducted at an issue price of $0.215 per share, resulting in the issuance of 116,279,070 new ordinary shares. The Placement was completed under the Company’s existing placement capacity pursuant to ASX Listing Rule 7.1. Shaw and Partners acted as lead manager and bookrunner to the placement. Following the placement, the Company’s total cash position has increased to over $35 million.

    In addition, Dateline has commenced the selection of a U.S. legal and an auditing firm to assist in the registration process with the U.S. Securities and Exchange Commission (SEC). This initiative will ensure Dateline’s financial statements and disclosures are fully compliant with SEC reporting standards. These strategic steps are designed to enhance Dateline’s visibility and accessibility to US investors, particularly as interest in the Colosseum Project grows amid increasing demand for domestic sources of critical minerals.

    This capital infusion will enable Dateline to expedite its drilling programs, building on recent geophysical surveys and geochemical results that have revealed significantly greater resource potential at Colosseum than initially anticipated. The funds will support the parallel advancement of both the gold and REE initiatives, positioning the Company to achieve production milestones at an accelerated pace. Proceeds from the Placement will be used to ramp up exploration and development at the Colosseum Gold and Rare Earth Elements (REE) Project in California. The new capital will enable the deployment of additional drill rigs to test the highest-priority targets, accelerating the timeline for resource growth and development. The Company is prioritizing early site works and long lead-time equipment orders (as part of the ongoing Bankable Feasibility Study) to fast-track the reopening of the Colosseum mine. Funds will also be applied toward general working capital and further business development opportunities as needed.

    Recent exploration highlights include the integration of a 3D magneto-telluric (MT) geophysical survey with detailed gravity data, leading to the identification of six new high-priority breccia pipe targets. These targets exhibit coincident geophysical anomalies, gravity lows and resistivity lows, similar to the known gold-bearing breccia pipes at Colosseum, which host the existing 1.1-million-ounce gold Mineral Resource Estimate (MRE) of 27.1Mt @ 1.26g/t Au, with over 67% in Measured and Indicated categories. Four of these new anomalies are comparable in scale or larger than those associated with the known pipes, and the MT results indicate the known structures extend to at least ~300 metres below prior drilling, suggesting substantial depth potential.

    In parallel, the 3D MT inversion has confirmed multiple high-priority REE drilling targets, including a prominent 2200N anomaly, a strong resistive feature extending from depth to surface, coincident with outcropping fenite dykes. This anomaly aligns with a relative gravity high and subdued magnetic response, characteristic of carbonatite-related REE systems similar to the nearby Mountain Pass mine. Deep resistivity structures have been identified beneath all mapped fenite outcrops, demonstrating consistency in the survey results and reinforcing the REE potential. Geochemical sampling from felsite outcrops has further confirmed gold-pathfinder elements coincident with gravity lows, enhancing confidence in these targets.

    U.S. Government Recognition and Support

    Dateline’s progress is further reinforced by strong support from the US government. In letters dated August 26, 2025, Secretary of the Interior Doug Burgum reaffirmed the validity of the Company’s existing rights at Colosseum, emphasizing the site’s role in advancing American energy independence and mineral production. Secretary Burgum noted that geologic information indicates the mine’s potential to produce gold and extract rare earth elements critical to national security and economic priorities, aligning with Executive Orders issued following the national energy emergency declaration on January 20, 2025. This endorsement highlights the US government’s commitment to responsible development of domestic resources, providing a solid foundation for Dateline’s operations.

    Building on this federal support, Dateline is continuing constructive discussions with government officials regarding potential funding and support mechanisms for Colosseum. The Company highlights that this $25 million private placement is complementary to, rather than a substitute for, ongoing pursuits of U.S. government-backed initiatives, reinforcing Colosseum’s role as a strategic contributor to America’s long-term minerals independence.

    Stephen Baghdadi, CEO and Managing Director of Dateline Resources, commented: “We are encouraged by the strong support from institutional investors, which validates our strategy at the Colosseum Project. Recent geophysical work has outlined six new gold targets with the same MT signature as the known breccia pipes and confirmed high-priority REE anomalies. With this funding, we are positioned to accelerate our dual-track development and unlock the significant potential value of the Colosseum.”

    Dateline Resources continues to advance its exploration and development activities with a focus on creating long-term shareholder value through innovation, efficiency, and environmental stewardship. Further updates on drilling results and project milestones will be provided in due course.

    About Dateline Resources Limited

    Dateline Resources Limited (ASX: DTR, OTC: DTREF) is an Australian publicly listed company focused on high-value mining and exploration in North America. Its flagship Colosseum Gold-REE Project in California’s Walker Lane Trend combines a proven gold resource with emerging rare earth potential, positioning Dateline as a leader in critical minerals and precious metals. The Colosseum Gold Mine is located in the Walker Lane Trend in East San Bernardino County, California. On 6 June 2024, the Company announced to the ASX that the Colosseum Gold mine has a JORC-2012 compliant Mineral Resource estimate of 27.1Mt @ 1.26g/t Au for 1.1Moz. Of the total Mineral Resource, 455koz @ 1.47/t Au (41%) are classified as Measured, 281koz @1.21g/t Au (26%) as Indicated and 364koz @ 1.10g/t Au (33%) as Inferred.

    On 23 May 2025, Dateline announced that updated economics for the Colosseum Gold Project generated an NPV6.5 of US$550 million and an IRR of 61% using a gold price of US$2,900/oz.

    The Colosseum is located less than 10km north of the Mountain Rare Earth mine. Planning has commenced on drill testing the REE potential at Colosseum.

    Forward-Looking Statements

    This press release contains “forward-looking statements” within the meaning of applicable securities laws. These statements relate to future events or performance, including the potential of the Colosseum Project, the benefits of U.S. government support, the company’s plans for future development, and the strategic importance of the project for U.S. critical minerals supply. Forward-looking statements are based on current expectations, estimates, and projections and are subject to risks and uncertainties that could cause actual results to differ materially. These risks include fluctuations in gold and rare earth element prices, changes in regulatory or permitting processes, geological or technical challenges, market conditions affecting capital raising, environmental or social factors, and risks related to securing government funding. Dateline Resources cautions readers not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The company undertakes no obligation to update or revise these statements, except as required by law.

    Contact Information

    Stephen Baghdadi
    Managing Director
    Dateline Resources Limited
    +61 2 9375 2353
    info@datelineresources.com.au
    www.datelineresources.com.au

    Andrew Rowell
    Corporate & Investor Relations Manager
    +61 400 466 226
    a.rowell@dtraux.com

    Follow Dateline on X: @Dateline_DTR

    This press release is authorized for release by the Board of Dateline Resources Limited.

    SOURCE: Dateline Resources Limited

    View the original press release on ACCESS Newswire

    The post Dateline Resources Completes $25M Institutional Placement Priced at $0.215 to Accelerate Development at Colosseum Gold and Rare Earth Project appeared first on DA80 Hub.

  • 1933 Industries Announces Repurchase and Cancellation of Convertible Debentures

    1933 Industries Announces Repurchase and Cancellation of Convertible Debentures

    VANCOUVER, BC / ACCESS Newswire / September 2, 2025 / 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce that it has entered into a Debenture Repurchase Agreement (the “Agreements”) with two arm’s length parties (together the “Vendors“), for the repurchase and cancellation of a portion of Company’s outstanding unsecured convertible debentures.

    Pursuant to the Agreements, the Company will repurchase $475,000 in principal value of debentures for a total cash consideration of $47,500 CAD. Upon closing, the debentures will be transferred, cancelled and removed from the Company’s outstanding liabilities.

    The Agreement is being conducted in accordance with the provisions of the trust indenture dated December 31, 2023, applicable securities laws, and the policies of the Canadian Securities Exchange (the “CSE“).

    The Company believes that the repurchase is in the best interest of shareholders and reflects its ongoing commitment to strengthening its balance sheet and reducing its liabilities. Following completion of the repurchase, an aggregate of $2,598,000 in principal value debentures will remain outstanding.

    The closing of the repurchase is subject to customary conditions and regulatory approvals, including any required filings with the CSE, and is expected to occur on or around September 5, 2025.

    About 1933 Industries Inc.

    1933 Industries is a Nevada-based licensed producer, focused on the cultivation and extraction of a large portfolio of cannabis consumer products in a variety of formats under its flagship brands, Alternative Medicine Association (AMA) and Level X. Its product offerings are cultivated at the Company’s 68,000 sq. ft. indoor facility and marketed directly to retail dispensaries. AMA branded flower, infused pre-rolls, and in-house boutique concentrates consistently rank as the top products sold in Nevada. For more information, please visit www.1933industries.com

    For further information please contact:
    Alexia Helgason, VP, Investor Relations
    604-728-4407
    alexia@1933industries.com

    Brian Farrell, Chairman and CEO
    brian@1933industries.com

    Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

    Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. 1933 Industries undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

    SOURCE: 1933 Industries Inc.

    View the original press release on ACCESS Newswire

    The post 1933 Industries Announces Repurchase and Cancellation of Convertible Debentures appeared first on DA80 Hub.

  • Inspire Veterinary Partners Regains Compliance with Nasdaq Listing Requirements

    Inspire Veterinary Partners Regains Compliance with Nasdaq Listing Requirements

    VIRGINIA BEACH, VIRGINIA / ACCESS Newswire / September 2, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (“Inspire” or the “Company”), an owner and provider of pet health care services throughout the U.S., announces that the Company has received formal notification on August 26, 2025 from the Nasdaq Stock Market (“Nasdaq”) determining that the Company now complies with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2.5 million in stockholders’ equity (“Equity Rule”).

    On April 10, 2025, the Company received formal notification from Nasdaq citing that it was out of compliance and needed to meet the requirements set forth under Listing rules 5550 (b)(1), 5550 (b)(2), or 5550 (b)(3). Confirmation of compliance was based on the Company’s Form 8-K dated August 20, 2025.

    About Inspire Veterinary Partners, Inc.

    Inspire Veterinary Partners is an owner and provider of pet health care services throughout the US. As the Company expands, it expects to acquire additional veterinary hospitals, including general practice, mixed animal facilities, and critical and emergency care. For more information, please visit: www.inspirevet.com.

    Facebook | LinkedIn | X

    Forward-Looking Statements

    This press release contains forward-looking statements regarding the Company’s current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, the Company’s ability to execute a definitive agreement relating to the proposed acquisition, satisfy closing conditions and otherwise complete the proposed acquisition, realize financial projections related to the proposed acquisition and complete additional acquisitions in the future. These and other risks and uncertainties are described more fully in the section captioned “Risk Factors” in the Company’s public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

    Investor Contact

    CoreIR
    Matt Blazei
    516-386-0430
    mattb@coreir.com

    Press Contact

    CORE IR
    Matthew Cossel
    pr@coreir.com

    General Inquires

    Morgan Wood
    Mwood@inspirevet.com

    SOURCE: INSPIRE VETERINARY PARTNERS, INC.

    View the original press release on ACCESS Newswire

    The post Inspire Veterinary Partners Regains Compliance with Nasdaq Listing Requirements appeared first on DA80 Hub.

  • Singapore’s A*STAR and SMX Lead Drive for World’s First Plastics Passport Program

    Singapore’s A*STAR and SMX Lead Drive for World’s First Plastics Passport Program

    Flagship programme will demonstrate molecular‑level traceability from waste collection to high‑value recycled resin, advancing Singapore’s Zero Waste Masterplan and reinforcing regional circular‑economy leadership.

    NEW YORK, NY AND SINGAPORE, SINGAPORE / ACCESS Newswire / September 2, 2025 / Security Matters PLC (NASDAQ:SMX; SMXWW), the pioneer of “physical‑to‑digital” supply‑chain solutions, and the Agency for Science, Technology and Research (A*STAR), Singapore’s lead public sector research and development (R&D) agency, today announced a strategic collaboration to pilot a national plastic circularity platform in partnership with leading brands, producers, manufacturers, waste collectors, recyclers and retailers.

    This partnership combines SMX’s chemical molecular marking technology, patented reader and blockchain-based traceability platform with A*STAR’s cutting-edge digital, advanced chemical spectroscopic detection and profiling research capabilities, creating an intelligent system to permanently mark, track and analyse plastics through their entire lifecycle-from manufacturing to recycling. By enabling every plastic item to carry a secure digital record of its origin, composition, and reuse cycles, the initiative aims to greatly enhance transparency and efficiency in recycling – supporting Singapore’s vision of a sustainable, circular economy

    This multi‑year partnership will integrate SMX’s invisible molecular markers, readers and blockchain ledger with blockchain, AI, advanced chemical spectroscopic detection and material profiling research capabilities from A*STAR, creating an auditable digital twin and AI system for post‑consumer plastic flows across Singapore’s collection, sorting and recycling ecosystem.

    Collaboration Highlights

    Phase 1 will launch the first nationwide “digital passport” for plastics, dynamically tagging and tracing more than 5 000 tonnes of postconsumer flexible and rigid waste in real time. Semi-industrial integration starts in Q1 2026, and a full scale commercial showcase is slated for Q2 2027-deliberately timed to provide industry with a turnkey compliance pathway ahead of impending extended producer responsibility mandates, with an end-stage capacity to tag and trace more than 5,000 tonnes of post-consumer plastics annually.

    The full-scale commercial tagging and tracing stage is envisioned to be powered by a coalition of global and local brands, regional retailers, resin producers, converters and recyclers – unlocking high‑value, mechanically recycled feedstock and demonstrating that true circularity is mission‑critical to economic resilience.

    Strategic Value & Market Context

    Singapore currently incinerates 94 % of the 957 000 tonnes of plastic it generates each year, recycling just 6 % – a costly gap that burns value as well as waste. If only one-third of that stream were captured in an SMX-verified loop, the nation would avoid roughly S$27 million in annual incineration fees and create a further S$75 million in saleable, certified post-consumer resin (PCR) – a compliance dividend worth more than S$100 million every year.

    The partnership between SMX and A*STAR is designed to flip that equation at scale. By embedding chemical molecular “barcodes” in every pellet and logging each hand-off on blockchain, the partners aim to lift regional recycling rates by more than 30 % and halve landfill or ash-fill volumes by 2030. When replicated across ASEAN, the same architecture unlocks an addressable market of ≈ S$4.2 billion a year in certified recycled material and platform fees – turning waste into a bankable commodity.

    Plastic Cycle Token – Turning Data into Value

    Each SMX-verified kilogram of recycled plastic will also be wrapped in a Plastic Cycle Token (PCT), a tradeable digital asset backed one-for-one by the molecular marker and its on-chain audit trail. The Plastic Cycle Token (PCT) is engineered to supersede traditional carbon credits – enabling recyclers to monetise verified recycled output, brands to hedge compliance risk, and investors to back measurable circularity

    Demand signals are loud and cross-sectoral. FMCG, food-grade packaging, electronics and automotive brands across China, India, Indonesia, Japan and Singapore are already specifying minimum-PCR thresholds and treating traceability as insurance against compliance shocks and brand-equity risk. In markets with real enforcement, verified PCR now commands a 5-15 % premium over virgin polymer, a spread expected to widen as Extended Producer Responsibility (EPR) schemes tighten.

    Against that backdrop, Phase 1 of the collaboration will create a nationwide digital passport for plastics, tagging and tracing thousands of tonnes of flexible and rigid waste in real time. The data stream will give producers a turnkey path to comply with Singapore’s Mandatory Packaging Reporting rules and forthcoming recycled-content mandates, while supplying recyclers with higher-value, mechanically recycled feedstock. In short, true circularity is no longer a nice-to-have – it is mission-critical to economic resilience and regional competitiveness.

    Haggai Alon, Founder & CEO, SMX:As Singapore marks 60 years of independence, it continues to prove that long-range planning, turns constraints into catalysts for growth.

    Together with A*STAR and our industry partners, we are building a bridge from Semakauto Jurong Island – transforming what was once a disposal endpoint into a high-value feedstock stream. This programme adds a new layer to Singapore’s leadership in technology and sustainability and places a powerful tool in the region’s master toolbox as Asia drives global growth.

    True circularity is driven by smart execution and adaptability. This is the first stage of a long-term plan-anchored by molecular traceability that converts waste into a verified commodity, and through the Plastic Cycle Token, a market instrument engineered to supersede traditional carbon credits with something measurable, auditable and economically useful.”

    Professor Lim Keng Hui, Assistant Chief Executive Officer of the Science & Engineering Research Council, A*STAR:This collaboration exemplifies A*STAR’s mission to translate cutting‑edge research into impactful, sustainable solutions. Together with SMX, we will harness science and engineering to close the plastics loop and strengthen Singapore’s position as a global circularity hub.”

    References

    1. National Environment Agency (NEA). Waste & Recycling Statistics 2014 – 2023. Singapore: NEA; 2024.

    2. Shunpoly.com. “How Much Plastic Is Wasted Each Year in Singapore?” Accessed 5 August 2025.

    3. National Environment Agency (NEA). Waste-Statistics & Overall Recycling (interactive dashboard). Updated 2024; accessed 5 August 2025.

    4. National Environment Agency (NEA). Mandatory Packaging Reporting portal. Accessed 5 August 2025.

    5. Singapore Statutes Online. Environmental Public Health (Public Cleansing) Regulations – Incineration gate-fee schedule; revised 2024.

    6. National Environment Agency (NEA). “New Licensing Regime for General Waste Disposal Facilities.” Technical brief & dialogue-session slides; 2024.

    7. Nasdaq.com. “SMX Announces Planned Launch of World’s First Plastic Cycle Token.” Press release; 2024.

    8. Yahoo! Finance. “SMX Plastic Cycle Token Is a Functional Market-Driven Solution…” News article; 2024.

    9. Los Angeles Tribune. “Carbon Credits Had Their Day… Now the SMX Plastic Cycle Token…” Feature article; 2025.

    10. National Environment Agency (NEA). Refuse Collection Fees for Households. Revised 2024; accessed 5 August 2025.

    For further information contact:

    SMX GENERAL ENQUIRIES

    Follow us through our social channel @secmattersltd

    E: info@securitymattersltd.com

    About SMX

    As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

    Forward-Looking Statements

    The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company’s fight against abusive and possibly illegal trading tactics against the Company’s stock; successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

    SOURCE: SMX (Security Matters)

    View the original press release on ACCESS Newswire

    The post Singapore’s A*STAR and SMX Lead Drive for World’s First Plastics Passport Program appeared first on DA80 Hub.

  • Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism

    Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism

    CAMBRIDGE, MA / ACCESS Newswire / September 2, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that five abstracts on its investigational mRNA therapeutics have been accepted for presentation at the 2025 International Congress of Inborn Errors of Metabolism (ICIEM), which will be held September 2-6, 2025 in Kyoto, Japan, at the Kyoto International Conference Center. This includes three oral presentations and two poster presentations across the Company’s propionic acidemia (PA), methylmalonic acidemia (MMA) and Glycogen Storage Disease Type 1a (GSD1a) programs. This is the first time Moderna will present data at a scientific congress for MMA and GSD1a.

    The details of the presentations are as follows:

    • Oral Presentation #8 – Organic Acidemias: Clinical Burden of Propionic Acidemia in Japan: A real-world evidence cohort study using a hospital-based healthcare database

      Time: Wednesday, September 3, 2025, 2:00 – 4:00 PM JST

      Order of Presentation: 1

      Location: Room 5

      Presenter: Yoko Nakajima

    • Oral Presentation #8 – Organic Acidemias: mRNA-3705 Therapy for Methylmalonic Acidemia: Interim Data from a Phase 1/2 Study

      Time: Wednesday, September 3, 2025, 2:00 – 4:00 PM JST

      Order of Presentation: 7

      Location: Room 5

      Presenter: Sabine Fuchs

    • Oral Presentation #8 – Organic Acidemias: mRNA-3927 for the Treatment of Propionic Acidemia: Final results from mRNA-3927-P101 Part 1 dose-escalation cohorts and cumulative data from ongoing participants

      Time: Wednesday, September 3, 2025, 2:00 – 4:00 PM JST

      Order of Presentation: 8

      Location: Room 5

      Presenter: Andreas Schulze

    • Poster Presentation #P-521: Model-Informed Dose Selection for the Pivotal Study of mRNA-3705 in Methylmalonic Acidemia

      Time: Wednesday, September 3, 2025, 6:00 – 7:00 PM JST

      Location: Poster 1 – Annex Hall

      Presenter: Min Liang

    • Poster Presentation #P-246: mRNA-3745 Therapy for GSD1a: Interim reported data from Phase 1/2 Ba1ance Study

      Time: Thursday, September 4, 2025, 5:30 – 6:30 PM JST

      Location: Poster 1 – Annex Hall

      Presenter: Nicola Longo

    About Moderna

    Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

    Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.

    Moderna Contacts

    Media:
    Chris Ridley
    Head of Global Media Relations
    +1 617-800-3651
    Chris.Ridley@modernatx.com

    Investors:
    Lavina Talukdar
    Senior Vice President & Head of Investor Relations
    +1 617-209-5834
    Lavina.Talukdar@modernatx.com

    SOURCE: Moderna, Inc.

    View the original press release on ACCESS Newswire

    The post Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism appeared first on DA80 Hub.

  • SMX and A*STAR Unite Industry Coalition to Build Nation-Scale Plastic Circularity Platform

    SMX and A*STAR Unite Industry Coalition to Build Nation-Scale Plastic Circularity Platform

    Flagship programme will demonstrate molecular-level traceability from waste collection to high-value recycled resin, advancing Singapore’s Zero Waste Masterplan and reinforcing regional circular-economy leadership.

    NEW YORK, NY AND SINGAPORE, SINGAPORE / ACCESS Newswire / September 2, 2025 / Security Matters PLC (NASDAQ:SMX)(NASDAQ:SMXWW), the pioneer of “physical-to-digital” supply-chain solutions, and the Agency for Science, Technology and Research (A*STAR), Singapore’s lead public sector research and development (R&D) agency, today announced a strategic collaboration to pilot a national plastic circularity platform in partnership with leading brands, producers, manufacturers, waste collectors, recyclers and retailers.

    This partnership combines SMX’s chemical molecular marking technology, patented reader, and secure digital traceability system with A*STAR’s cutting-edge digital, advanced chemical spectroscopic detection and profiling research capabilities, creating an intelligent system to permanently mark, track and analyse plastics through their entire lifecycle-from manufacturing to recycling. By enabling every plastic item to carry a tamper-proof digital record of its origin, composition, and reuse cycles, the initiative aims to greatly enhance transparency and efficiency in recycling-supporting Singapore’s vision of a sustainable, circular economy.

    This multi-year partnership will integrate SMX’s invisible molecular markers and readers with AI, advanced chemical spectroscopic detection, and material-profiling research from A*STAR, creating an auditable digital twin and verification system for post-consumer plastic flows across Singapore’s collection, sorting, and recycling ecosystem.

    Collaboration Highlights

    Phase 1 will launch the first nationwide “digital passport” for plastics, dynamically tagging and tracing more than 5,000 tonnes of post-consumer flexible and rigid waste in real time. Semi-industrial integration starts in Q1 2026, and a full-scale commercial showcase is slated for Q2 2027-deliberately timed to provide industry with a turnkey compliance pathway ahead of impending extended producer responsibility mandates, with an end-stage capacity to tag and trace more than 5,000 tonnes of post-consumer plastics annually.

    The full-scale commercial tagging and tracing stage is envisioned to be powered by a coalition of global and local brands, regional retailers, resin producers, converters and recyclers-unlocking high-value, mechanically recycled feedstock and demonstrating that true circularity is mission-critical to economic resilience.

    Strategic Value & Market Context

    Singapore currently incinerates 94% of the 957,000 tonnes of plastic it generates each year, recycling just 6%-a costly gap that burns value as well as waste. If only one-third of that stream were captured in an SMX-verified loop, the nation would avoid roughly S$27 million in annual incineration fees and create a further S$75 million in saleable, certified post-consumer resin (PCR)-a compliance dividend worth more than S$100 million every year.

    The partnership between SMX and A*STAR is designed to flip that equation at scale. By embedding chemical molecular “barcodes” in every pellet and recording each hand-off in a secure digital ledger, the partners aim to lift regional recycling rates by more than 30% and halve landfill or ash-fill volumes by 2030. When replicated across ASEAN, the same architecture unlocks an addressable market of ≈ S$4.2 billion a year in certified recycled material and platform fees-turning waste into a bankable commodity.

    Plastic Cycle Token – Turning Data into Value

    Each SMX-verified kilogram of recycled plastic will also be wrapped in a Plastic Cycle Token (PCT), a tradeable market instrument backed one-for-one by the molecular marker and its verified audit trail. The PCT is engineered to supersede traditional carbon credits-enabling recyclers to monetise verified recycled output, brands to hedge compliance risk, and investors to back measurable circularity.

    Demand signals are loud and cross-sectoral. FMCG, food-grade packaging, electronics, and automotive brands across China, India, Indonesia, Japan, and Singapore are already specifying minimum-PCR thresholds and treating traceability as insurance against compliance shocks and brand-equity risk. In markets with real enforcement, verified PCR now commands a 5-15% premium over virgin polymer, a spread expected to widen as Extended Producer Responsibility (EPR) schemes tighten.

    Against that backdrop, Phase 1 of the collaboration will create a nationwide digital passport for plastics, tagging and tracing thousands of tonnes of flexible and rigid waste in real time. The data stream will give producers a turnkey path to comply with Singapore’s Mandatory Packaging Reporting rules and forthcoming recycled-content mandates, while supplying recyclers with higher-value, mechanically recycled feedstock. In short, true circularity is no longer a nice-to-have-it is mission-critical to economic resilience and regional competitiveness.

    Leadership Commentary

    Haggai Alon, Founder & CEO, SMX: “As Singapore marks 60 years of independence, it continues to prove that long-range planning turns constraints into catalysts for growth. Together with A*STAR and our industry partners, we are building a bridge from Semakauto Jurong Island-transforming what was once a disposal endpoint into a high-value feedstock stream. This programme adds a new layer to Singapore’s leadership in technology and sustainability and places a powerful tool in the region’s master toolbox as Asia drives global growth.

    True circularity is driven by smart execution and adaptability. This is the first stage of a long-term plan-anchored by molecular traceability that converts waste into a verified commodity, and through the Plastic Cycle Token, a market instrument engineered to supersede traditional carbon credits with something measurable, auditable, and economically useful.”

    Professor Lim Keng Hui, Assistant Chief Executive Officer of the Science & Engineering Research Council, A*STAR:“This collaboration exemplifies A*STAR’s mission to translate cutting-edge research into impactful, sustainable solutions. Together with SMX, we will harness science and engineering to close the plastics loop and strengthen Singapore’s position as a global circularity hub.”

    References

    1. National Environment Agency (NEA). Waste & Recycling Statistics 2014 – 2023. Singapore: NEA; 2024.

    2. Shunpoly.com. “How Much Plastic Is Wasted Each Year in Singapore?” Accessed 5 August 2025.

    3. National Environment Agency (NEA). Waste-Statistics & Overall Recycling (interactive dashboard). Updated 2024; accessed 5 August 2025.

    4. National Environment Agency (NEA). Mandatory Packaging Reporting portal. Accessed 5 August 2025.

    5. Singapore Statutes Online. Environmental Public Health (Public Cleansing) Regulations – Incineration gate-fee schedule; revised 2024.

    6. National Environment Agency (NEA). “New Licensing Regime for General Waste Disposal Facilities.” Technical brief & dialogue-session slides; 2024.

    7. Nasdaq.com. “SMX Announces Planned Launch of World’s First Plastic Cycle Token.” Press release; 2024.

    8. Yahoo! Finance. “SMX Plastic Cycle Token Is a Functional Market-Driven Solution…” News article; 2024.

    9. Los Angeles Tribune. “Carbon Credits Had Their Day… Now the SMX Plastic Cycle Token…” Feature article; 2025.

    10. National Environment Agency (NEA). Refuse Collection Fees for Households. Revised 2024; accessed 5 August 2025.

    For further information contact:
    Email: info@securitymatters.com

    About SMX

    As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

    Forward-Looking Statements

    The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company’s fight against abusive and possibly illegal trading tactics against the Company’s stock; successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

    SOURCE: SMX (Security Matters)

    View the original press release on ACCESS Newswire

    The post SMX and A*STAR Unite Industry Coalition to Build Nation-Scale Plastic Circularity Platform appeared first on DA80 Hub.

  • Brenmiller Advances Tempo and Wolfson TES Projects Expected to Generate Revenue from bGen Starting 2026

    Brenmiller Advances Tempo and Wolfson TES Projects Expected to Generate Revenue from bGen Starting 2026

    Brenmiller outlines key upcoming project milestones at Tempo and Wolfson

    ROSH HA‘AYIN, IL / ACCESS Newswire / September 2, 2025 / Brenmiller Energy Ltd. (Nasdaq:BNRG), (the “Company”, “Brenmiller” or “Brenmiller Energy”) a leading global provider of Thermal Energy Storage (“TES”) solutions for industrial and utility customers, today outlined key upcoming milestones for the Tempo Beverages Ltd. (“Tempo”) and Wolfson Medical Center (“Wolfson”) projects. In addition, the Company has numerous projects in development through joint ventures, as well as a robust global pipeline of opportunities valued in hundreds of millions of dollars.

    “Tempo and Wolfson are the first in a series of revenue-generating projects that will scale our technology, our sales, and our impact,” stated Avi Brenmiller, Chairman and Chief Executive Officer of Brenmiller Energy. “Tempo is expected to enter commercial operation and revenue generation in 2026, with Wolfson is ramping up for revenues by the end of 2026 or early 2027. This marks an important shift from project development to revenue execution and validates the Company’s capital-efficient Energy as a Service (EaaS) approach.”

    Tempo Project Execution Timeline

    Once commissioned, Brenmiller’s bGen™ ZERO will replace Tempo’s fossil fuel boilers and serve as the beverage processor’s primary heat source at its Nethanya, Israel facility. The switch from heavy fuel oil to electricity is estimated to mitigate over 6,200 tons of carbon emissions annually and save Tempo an estimated $7.5 million over 15 years. Tempo is partially owned by Heineken International B.V. and produces and distributes brands including Heineken and Pepsi. As of today, the expected project execution timeline for the Tempo project is:

    • Q4 2025 – End of construction and entering commissioning

    • H1 2026 – Full customer acceptance test completed

    Wolfson Hospital Project Execution Timeline

    bGen™ ZERO’s power-to-heat TES will replace diesel boilers at Wolfson Hospital in Holon, Israel. The TES will be charged from grid electricity at off-peak hours to produce saturated steam and hot water around the clock 24/7/365. According to the Israeli Ministry of Finance’s estimates, electric heat provided via Brenmiller’s bGen™ ZERO has the potential to save Wolfson up to $1.3 million annually and reduce the hospital’s local carbon footprint by 3,900 tons per year. Progress at Wolfson Hospital is on track, with early construction and component production already initiated. As of today, the expected project execution timeline for the Wolfson Hospital project is:

    • Q4 2025 – Civil works

    • Q3 2026 – Construction completion

    • Q4 2026 – Commissioning

    • H1 2027 – Full customer acceptance test completed

    About bGen™

    bGen™ ZERO is Brenmiller’s TES system, which converts electricity into heat to power sustainable industrial processes at a price that is competitive with natural gas. The bGen™ ZERO charges by capturing low-cost electricity from renewables or the grid and stores it in crushed rocks. It then discharges steam, hot water, or hot air on demand according to customer requirements. The bGen™ ZERO also supports the development of utility-scale renewables by providing critical flexibility and grid-balancing capabilities. bGen™ ZERO was named among TIME’s Best Inventions of 2023 in the Green Energy category and won Gold in the Energy Storage and Management category at the 2025 Edison Awards.

    About Brenmiller Energy Ltd.

    Brenmiller Energy helps energy-intensive industries and power producers end their reliance on fossil fuel boilers. Brenmiller’s patented bGen™ ZERO thermal battery is a modular and scalable energy storage system that turns renewable electricity into zero-emission heat. It charges using low-cost renewable electricity and discharges a continuous supply of heat on demand and according to its customers’ needs. The most experienced thermal battery developer on the market, Brenmiller operates the world’s only gigafactory for thermal battery production and is trusted by leading multinational energy companies. For more information visit the Company’s website at https://bren-energy.com/ and follow the company on X and LinkedIn.

    Forward-Looking Statements

    This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements when discussing: the revenue that will be generated from the Tempo and Wolfson projects and timeline; that the Tempo project is expected to enter commercial operation in January 2026, and Wolfson ramping up for revenues by the end of 2026 or early 2027; that the Tempo and Wolfson projects mark an important shift from project development to revenue execution and validates the Company’s capital-efficient EaaS approach. Without limiting the generality of the foregoing, words such as “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate” or “continue” are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this press release. Factors that may affect the Company’s results include, but are not limited to: the Company’s planned level of revenues and capital expenditures; risks associated with the adequacy of existing cash resources; the demand for and market acceptance of our products; impact of competitive products and prices; product development, commercialization or technological difficulties; the success or failure of negotiations; trade, legal, social and economic risks; and political, economic and military instability in the Middle East, specifically in Israel. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission (“SEC”) on March 4, 2025, which is available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

    Contact: investors@bren-energy.com

    SOURCE: Brenmiller Energy

    View the original press release on ACCESS Newswire

    The post Brenmiller Advances Tempo and Wolfson TES Projects Expected to Generate Revenue from bGen Starting 2026 appeared first on DA80 Hub.